Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Lisa Rydén"'
Autor:
Sophia Zackrisson, Anna Gardfjell, Kristina Åhsberg, Catharina Behmer, Lisa Rydén, Emma Niméus, Rogvi W Rasmussen
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Objectives The aim of this feasibility study was to evaluate the added value of contrast-enhanced mammography (CEM) in preoperative staging of malignant breast lesions, beyond standard assessment with digital mammography and ultrasound, as a base for
Autor:
Charlotte Jørgensen, Carina Forsare, Anna Karin Falck, Kristina Lövgren, Mårten Fernö, Pär-Ola Bendahl, Kristina Aaltonen, Lisa Rydén
Publikováno v:
Breast Cancer Research and Treatment
Purpose The study aimed to investigate expression of epithelial-to-mesenchymal transition (EMT)-related proteins and phenotypes during breast cancer progression and to relate this to patient outcome. Methods Protein expression patterns of E-cadherin,
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
Autor:
Malin, Dahlgren, Anthony M, George, Christian, Brueffer, Sergii, Gladchuk, Yilun, Chen, Johan, Vallon-Christersson, Cecilia, Hegardt, Jari, Häkkinen, Lisa, Rydén, Martin, Malmberg, Christer, Larsson, Sofia K, Gruvberger-Saal, Anna, Ehinger, Niklas, Loman, Åke, Borg, Lao H, Saal
Publikováno v:
JNCI Cancer Spectrum
Background More than three-quarters of primary breast cancers are positive for estrogen receptor alpha (ER; encoded by the gene ESR1), the most important factor for directing anti-estrogenic endocrine therapy (ET). Recently, mutations in ESR1 were id
Autor:
Lao H. Saal, Christian Brueffer, Yilun Chen, Anthony M. George, Lisa Rydén, Niklas Loman, Kristina Aaltonen, Daniel Förnvik, Robert Rigo
Publikováno v:
Breast Cancer Research and Treatment
Purpose It is not known if mammographic breast compression of a primary tumor causes shedding of tumor cells into the circulatory system. Little is known about how the detection of circulating biomarkers such as circulating tumor cells (CTCs) or circ
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer
BMC Cancer
Background Sentinel node biopsy (SNB) is the standard procedure for axillary staging in patients with clinically lymph node negative invasive breast cancer. Completion axillary lymph node dissection (c-ALND) may not be necessary for all patients as a
Autor:
L. M. Fredrik Leeb-Lundberg, Christian Ingvar, Ulrik Narbe, Carina Forsare, Kristina Lövgren, Sara Alkner, Mårten Fernö, Lisa Rydén, Martin Sjöström, Pär-Ola Bendahl
Publikováno v:
Breast Cancer Research and Treatment
Purpose According to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, progesterone receptor (PR) and Nottingham histological grade (NHG) are used for prognostic classification of estrogen receptor (ER) positive/HER2-negative
Autor:
Mårten Fernö, Dorthe Grabau, Carina Forsare, Olle Stål, Marie Sundqvist, Pär-Ola Bendahl, Lisa Rydén, Martin Bak, Per-Uno Malmström, Anna Karin Falck, Fredrika Killander
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Forsare, C, Bak, M, Falck, A K, Grabau, D, Killander, F, Malmström, P, Rydén, L, Stål, O, Sundqvist, M, Bendahl, P O & Fernö, M 2018, ' Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer ', BMC Cancer, vol. 18, 1226 . https://doi.org/10.1186/s12885-018-5123-x
BMC Cancer
Forsare, C, Bak, M, Falck, A K, Grabau, D, Killander, F, Malmström, P, Rydén, L, Stål, O, Sundqvist, M, Bendahl, P O & Fernö, M 2018, ' Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer ', BMC Cancer, vol. 18, 1226 . https://doi.org/10.1186/s12885-018-5123-x
BMC Cancer
BackgroundPrognostic factors in breast cancer are often measured on a continuous scale, but categorized for clinical decision-making. The primary aim of this study was to evaluate if accounting for continuous non-linear effects of the three factors a
Publikováno v:
The British journal of surgery. 108(12)
The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omission of completion axillary lymph node dissection (cALND), regardless of histological type, in patients with one or two sentinel lymph node (SLN) metastases. Concu
Autor:
Jean-Yves Pierga, Mireia Margeli, Florin Andrei Taran, Tanja Fehm, Vincent P. Walter, Birgitt Schoenfisch, Florian Schuetz, Klaus Pantel, Oliver Hoffmann, Sabine Kasimir-Bauer, Markus Wallwiener, Wolfgang Janni, Gerhard Gebauer, Nadia Harbeck, Lisa Rydén, Alexandra von Au, Christoph Klein, Andreas D. Hartkopf, Sara Y. Brucker, Brigitte Rack, Mårten Fernö, Katherine N. Weilbaecher, Matthias W. Beckmann, Christoph Domschke, François-Clément Bidard, Elin Borgen, Markus Hahn, Julia Kathrin Jueckstock, Bjørn Naume, Peter A. Fasching, Diethelm Wallwiener, Montserrat Solá, Natalia Krawczyk, Minh Hanh Ta, Rebecca Aft, Ann Kathrin Bittner, A. Kurt
Publikováno v:
European Journal of Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Purpose: Presence of disseminated tumour cells (DTCs) in the bone marrow (BM) has been described as a surrogate of residual disease in patients with early breast cancer (EBC). PADDY (Pooled Analysis of DTC Detection in Early Breast Cancer) is a large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67847c31c60f438edaf96d354653c12b
https://www.ncbi.nlm.nih.gov/pubmed/34265505
https://www.ncbi.nlm.nih.gov/pubmed/34265505
Autor:
Olle Stål, Svanheiður Rafnsdóttir, Éamon Hughes, Göran Landberg, Karoline Berger, Maria Ekholm, Ylva Magnusson, Lisa Rydén, Sara Rhost
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Background The growth factor progranulin has been implicated in numerous biological processes such as wound healing, inflammation and progressive tumorigenesis. Both progranulin and its receptor sortilin are known to be highly expressed in subgroups